Eccentric compression dressing for intravenous closure treatment and production method thereof

A production method and post-treatment technology, applied in the direction of drug combinations, pharmaceutical formulas, plant raw materials, etc., can solve problems such as wound infection, achieve the effects of reducing pain, shortening healing time, and promoting the healing of bleeding wounds

Inactive Publication Date: 2018-11-20
BEIJING SHIJITAN HOSPITAL CAPITAL MEDICAL UNIVERSTY
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The existing hemostatic dressing utilizes mineral hemostatic particles as part of the hemostatic material. The mineral particles are bonded to the support matrix under the action of the adhesive. When the mineral particles come into contact with the wound, it is easy to cause wound infection. Therefore, It is necessary to produce an eccentric compression dressing capable of rapid hemostasis and capable of sterilizing after vein closure therapy and its production method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eccentric compression dressing for intravenous closure treatment and production method thereof
  • Eccentric compression dressing for intravenous closure treatment and production method thereof
  • Eccentric compression dressing for intravenous closure treatment and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1: An eccentric compression dressing for venous closure treatment, comprising hemostatic gauze and a mesh cover wrapped in the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 4 parts of nettle root, 5 parts of bletilla striata, 2 parts of dandelion, 3 parts of dandelion 1 part forsythia and 1 part puffball.

[0044] Wherein the hemostatic gauze comprises fabric, the hemostatic agent impregnated on the fabric, bactericidal disinfectant, scar remover, analgesic and healing agent; wherein the mass ratio of hemostatic agent, bactericidal disinfectant, scar remover, analgesic and healing agent is 1.3:0.6:0.2:0.1:0.3;

[0045] The hemostatic agent is prepared from the following ingredie...

Embodiment 2

[0057] Embodiment 2: An eccentric compression dressing for venous closure treatment, comprising hemostatic gauze and a mesh cover wrapped outside the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and hemostatic A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the side where the gauze contacts; 3.5 parts forsythia and 2 parts puffball.

[0058] Wherein the hemostatic gauze comprises fabric, the hemostatic agent impregnated on the fabric, bactericidal disinfectant, scar remover, analgesic and healing agent; wherein the mass ratio of hemostatic agent, bactericidal disinfectant, scar remover, analgesic and healing agent is 1.4:0.75:0.3:0.15:0.4;

[0059] The hemostatic agent is prepared from the following ingredients in parts by mass: 6.5 parts of huanglongwei, 9 parts of iron amaranth, 5.5 parts of rich cabbage, 7 parts of seabuckthorn oil, 4.5 parts of sodium ed...

Embodiment 3

[0071] Embodiment 3: An eccentric compression dressing for venous closure treatment, comprising hemostatic gauze and a mesh cover wrapped in the hemostatic gauze to prevent the hemostatic gauze from spreading; the mesh cover is made of elastic material; the mesh cover and the hemostatic gauze A viscose layer for adhering the hemostatic gauze to the hemostatic gauze is arranged on the contacting side; the viscose layer is made of the following components in parts by mass: 6 parts of nettle root, 8 parts of bletilla striata, 3 parts of dandelion, 4 parts by mass. 1 part forsythia and 3 parts puffball.

[0072] Wherein the hemostatic gauze comprises fabric, the hemostatic agent impregnated on the fabric, bactericidal disinfectant, scar remover, analgesic and healing agent; wherein the mass ratio of hemostatic agent, bactericidal disinfectant, scar remover, analgesic and healing agent is 1.53:0.9:0.4:0.2:0.5;

[0073] The hemostatic agent is prepared from the following ingredient...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an eccentric compression dressing for intravenous closure treatment, and relates to the technical field of hemostatic materials. The key point of the technical scheme is that the eccentric compression dressing comprises a hemostatic gauze, the hemostatic gauze comprises a fabric and a hemostatic agent and a disinfectant soaked in the fabric; the hemostatic agent is preparedfrom the following ingredients by weight: 5-8 parts of agrimonia pilosa, 8-10 parts of acalypha australis, 4-7 parts of gynura divaricate, 5-9 parts of sea buckthron oil, 3-6 parts of edetate sodium,2-4 parts of pseudo-ginseng, 1-3 parts of alpine stonecrop, 2.5-3.5 parts of mirabilite, 1.5-2.5 parts of rheum officinale, 1-3 parts of flos sophorae, 3-4 parts of hairyvein agrimony, 3-4 parts of folium artemisiae argyi, and 1-3 parts of cattail pollen; the disinfectant is prepared from the following ingredients by weight: 9-11 parts of cinnamon, 5-9 parts of mile swertia, 3-8 parts of polygonatum odoratum, and 2-5 parts of radix angelicae. The eccentric compression dressing solves the problems that the time for stopping bleeding is long and the wound is easily infected, and achieves the effects of rapidly stopping bleeding, sterilizing and disinfecting.

Description

technical field [0001] The invention relates to the technical field of medical hemostatic materials, more specifically, it relates to an eccentric compressive dressing for vein closure treatment and a production method thereof. Background technique [0002] When treating varicose veins, it is necessary to puncture the bleeding port on the blood vessels of the varicose veins in the leg, then cover the bleeding port with hemostatic gauze, put on varicose vein socks, and fix the hemostatic gauze on the bleeding port to heal the bleeding port. [0003] In the prior art, you can refer to the Chinese invention patent document with the authorized announcement number CN103800940B, which discloses a hemostatic dressing and its preparation method, including the following steps: weighing mineral hemostatic particles, softener, adhesive, and antibacterial material , procoagulant material and water; mineral hemostatic granules, softener, and adhesive are added to water and mixed, boiled,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61L15/40A61L15/46A61L15/44A61K36/88A61K36/896A61K36/886A61P7/04A61P29/00A61P17/02A61P31/02A61K31/045A61K31/198A61K31/375A61K31/4415A61K31/525A61K31/714A61K33/04A61K35/644
CPCA61K31/045A61K31/198A61K31/375A61K31/4415A61K31/525A61K31/714A61K33/04A61K35/644A61K36/185A61K36/232A61K36/258A61K36/282A61K36/324A61K36/33A61K36/41A61K36/47A61K36/48A61K36/489A61K36/51A61K36/54A61K36/708A61K36/73A61K36/88A61K36/886A61K36/896A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61L15/40A61L15/44A61L15/46A61L2300/30A61L2300/404A61L2300/418A61P7/04A61P17/02A61P29/00A61P31/02A61K2300/00
Inventor 牛鹿原张欢
Owner BEIJING SHIJITAN HOSPITAL CAPITAL MEDICAL UNIVERSTY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products